Double biologics expansion for CMOs Gallus and Cytovance
Contract manufacturers Cytovance and Gallus have both invested millions of dollars in expanding their biologics-manufacturing facilities.
Archives for January 31, 2014
Sanofi, Transgene to build €10m manufacturing plant for immunotherapy
Sanofi and French biopharma Transgene will soon begin construction on their new €10m ($13.5m) manufacturing plant, which will produce viral vectors for Transgene's targeted cancer immunotherapy, TG4010.
Thermo Fisher: 'Life begins in February,' as it awaits FTC approval
Thermo Fisher has predicted its $13.6bn takeover of Life Technologies will be completed in February as it reports strong FY 2013 results.
GSK: Halt in chicken pox vaccine manufacture to continue into Q2
Shipments of chicken pox vaccines from a troubled Belgian facility should recommence in early Q2 2014, says GSK, though the root cause of the manufacturing issues are still unknown.